Alcacer, J. and Gittelman, M.: 2004, How do I know what you know? Patent examiners and the generation of patent citations, New York University, mimeo Anton, J. and Yao, D.: 2003, Patents, Invalidity, and the Strategic Transmission of Enabling Information, Journal of Economics ~ Management Strategy 12(2), isi-i78. Arora, A., Gambardella, A. and Fosfuri, A.: 200i, Markets for Technology: The Economics of Innovation and Corporate Strategy, MIT Press. Arrow, K.: i962, Economic Welfare and the Allocation of Resources for Invention, in R. Nelson (ed.), The Rate and Direction of Inventive Activity: Economic and Social Factors, Princeton, NJ: Princeton University Press.
- Baker, S., Lichtman, D. and Mezzetti, C.: 2005, Disclosure and investment as strategies in the patent race, Journal of Law and Economics 48, i73i94.
Paper not yet in RePEc: Add citation now
- Chan, A.-W., Hrobjartsson, A., Haahr, M., Gotzsche, P. and Altman, D.: 2004, Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials, Journal of the American Medical Association 291(20), 2457-2465.
Paper not yet in RePEc: Add citation now
Cohen, W., Nelson, R. and Walsh, J.: 2000, Protecting Their Intellectual Assets: Appropriability Conditions and Why US Manufacturing Firms Patent (or Not). 225ee Section 801.
- Dallavalle, S., Merhni, L., Penco, S. and Zunino, F.: 2002, Perspective in camptothecin development, Expert Opinions on Therapeutic Patents 12, 837-844.
Paper not yet in RePEc: Add citation now
- David, P., Mowery, D. and Steinmuller, E.: 1992, Analyzing the Economic Payoffs from Basic Research, Economics of Innovation and New Technology 2, 73-90.
Paper not yet in RePEc: Add citation now
- DiMasi, J.: 1995, Success rates for new drugs entering clinical testing in the United States, Clinical Pharmacology &~ Therapeutics 58(1), 1-14.
Paper not yet in RePEc: Add citation now
Gambardella, A.: 1995, Science and Innovation: The US Pharmaceutical Industry in the 1980 s, Cambridge University Press.
Hall, B., Jaffe, A. and Trajtenberg, M.: 2001, The NBER Patent Citation Data File: Lessons, Insights and Methodological Tools.
Harhoff, D., Narin, F., Scherer, F. and Vopel, K.: 1999, Citation Frequency and the Value of Patented Inventions, The Review of Economics and Statistics 81(3), 511-515.
- Heller, M. and Eisenberg, R.: 1998, Can Patent Deter Innovation? The Anti-Commons in Biomedical Research, Science 280, 698-101.
Paper not yet in RePEc: Add citation now
Henderson, R. and Cockburn, I.: 1996, Scale, Scope, and Spillovers: The Determinants of Research Productivity in Drug Discovery, Rand Journal of Economics 27(1), 32-59.
Henderson, R., Orsenigo, L. and Pisano, G.: 1999, The Pharmaceutical Industry and the Revolution in Molecular Biology: Exploring the Interactions between Scientific, Institutional and Organizational Change, in D. Mowery and R. Nelson (eds), Sources of Industrial Leadership, Cambridge University Press: Cambrigde, MA.
Horstmann, I., MacDonald, G. and Slivinski, A.: 1985, Patents as Information Transfer Mechanisms: To Patent or (Maybe) Not to Patent, The Journal of Political Economy 93(5), 837-858.
- Hsiang, Y., Hertzberg, R., Hecht, S. and Liu, L.: 1985, Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I, Journal of Biological Chemistry 260(27), 14873-14878. Jaffe, A. and Trajtenberg, M.: i996, Flows of Knowledge from Universities and Federal Labs: Modeling the Flow of Patent Citations Over Time and Across Institutional and Geographic Boundaries.
Paper not yet in RePEc: Add citation now
- Jaffe, A. and Trajtenberg, M.: 2002, Patents, citations and innovations: a window on the knowledge economy, MIT Press.
Paper not yet in RePEc: Add citation now
Jaffe, A., Trajtenberg, M. and Fogarty, M.: 2000, The Meaning of Patent Citations: Report on the NBER/Case-Western Reserve Survey of Patentees.
- Janis, M.: 2000, On Courts Herding Cats: Contending with the Written Description Requirement (and Other Unruly Patent Disclosure Doctrines) , Washington University Journal of Law and Policy 2, 55-108.
Paper not yet in RePEc: Add citation now
- Johnson, R. and Dickersin, K.: 2007, Publication bias against negative results from clinical trials: three of the seven deadly sins, Nature Clinical Practice Neurology 3(u), 590-59i.
Paper not yet in RePEc: Add citation now
- Landes, W. and Posner, R.: 2003, The economic structure of intellectual property law, Belknap Press of Harvard University Press Cambridge, Mass. Lanjouw, J. and Schankerman, M.: i999, The Quality of Ideas: Measuring Innovation with Multiple Indicators. Lee, J., Laydon, J., McDonnell, P., Gallagher, T., Kumar, S., Green, D., McNulty, D., Blumenthal, M., Keys, J., Land Vatter, S. et al.: i994, A protein kinase involved in the regulation of inflammatory cytokine biosynthesis, Nature 372(6508), 739-746. Levin, R., Klevorick, A., Nelson, R., Winter, S., Gilbert, R. and Griliches, Z.: i987, Appropriating the Returns from Industrial Research and Development, Brookings Papers on Economic Activity Microeconomics (3), 783-83i.
Paper not yet in RePEc: Add citation now
- Lichtman, D., Baker, S. and Kraus, K.: 2000, Strategic Disclosure in the Patent System, Vanderbilt Law Review 53, 2i75-22i7. Machlup, F. and Penrose, E.: i950, The Patent Controversy in the Nineteenth Century, The Journal of Economic History 10(i), i-29. Mansfield, E.: i986, Patents and Innovation: An Empirical Study, Management Science 32(2), i73-i8i.
Paper not yet in RePEc: Add citation now
- Mervis, J.: 2005, Productivity Counts-But the Definition Is Key.
Paper not yet in RePEc: Add citation now
Murray, F. and Stern, 5.: 2007, Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-Commons Hypothesis, Journal of Economic Behavior and Organization 63(4), 648-687.
- Oppenheim, C.: 1998, How SMEs use the patent literature.
Paper not yet in RePEc: Add citation now
- Oprea, T., Davis, A., Teague, S. and Leeson, P.: 2001, Is There a Difference between Leads and Drugs? A Historical Perspective, Journal of Chemical Information and Computer Sciences 41(5), 1308-1315.
Paper not yet in RePEc: Add citation now
Orsenigo, L., Pammolli, F. and Riccaboni, M.: 2001, Technological change and network dynamics: lessons from the pharmaceutical industry, Research Policy 30(3), 485-508.
- Parchomovsky, G.: 2000, Publish or Perish, Michigan Law Review 98(4), 926-952.
Paper not yet in RePEc: Add citation now
- Plant, A.: 1934, The Economic Theory Concerning Patents for Inventions, in R. . K. Paul (ed.), Selected Economic Essays and Addresses, London, pp. 35-36.
Paper not yet in RePEc: Add citation now
- Reichman, J.: 1995, Universal Minimum Standards of Intellectual Property Protection under the TRIPS Component of the WTO Agreement, International Lawyer 29, 345-388.
Paper not yet in RePEc: Add citation now
Scotchmer, S. and Green, J.: 1990, Novelty and Disclosure in Patent Law, The RAND Journal of Economics 2 1(1), 131-146.
- Sutton, J.: 1998, Technology and market structure: theory and history, The MIT Press Cambridge, Mass.
Paper not yet in RePEc: Add citation now
- Tang, P., Adams, J. and Pare, D.: 2001, Patent protection of computer programmes, Report submitted to the European Commission -Directorate-General Enterprise.
Paper not yet in RePEc: Add citation now
- Trajtenberg, M., Henderson, R. and Jaffe, A.: 1997, University vs. Corporate Patents: A Window on the Basicness of Innovations, Economics of Innovation and New Technology 5(1), 19-SO.
Paper not yet in RePEc: Add citation now
Trajtenberg, M.: 1990, A Penny for Your Quotes: Patent Citations and the Value of Innovations, The RAND Journal of Economics 21(1), 172-187.
- Wall, M., Wani, M., Cook, C., Palmer, K., McPhail, A. and Sim, G.: 1966, Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminatal, 2, Journal of the American Chemical Society 88(16), 3888-3890.
Paper not yet in RePEc: Add citation now
- WHO: 2006, Public Health: Innovation and Intellectual Property Rights.
Paper not yet in RePEc: Add citation now
- Zarin, A. and Tse, T.: 2008, Moving Toward Transparency of Clinical Trials, Science 319(5868), 1340-1342.
Paper not yet in RePEc: Add citation now